Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders
{{output}}
Psychedelic compounds have shown extraordinary potential in treating a wide range of neuropsychiatric disorders. Psilocybin, for example, has now been shown in several clinical trials to induce a rapid (within days) and persistent (3-12 months) improvement in ... ...
